These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 10642057)

  • 1. L-carnitine supplementation in patients with cystic acne on isotretinoin therapy.
    Georgala S; Schulpis KH; Georgala C; Michas T
    J Eur Acad Dermatol Venereol; 1999 Nov; 13(3):205-9. PubMed ID: 10642057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Creatine phosphokinase values during isotretinoin treatment for acne.
    Kaymak Y
    Int J Dermatol; 2008 Apr; 47(4):398-401. PubMed ID: 18377609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of laboratory data in acne patients treated with isotretinoin: is there really a need to perform routine laboratory tests?
    Alcalay J; Landau M; Zucker A
    J Dermatolog Treat; 2001 Mar; 12(1):9-12. PubMed ID: 12171680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Muscular damage during isotretinoin treatment].
    Heudes AM; Laroche L
    Ann Dermatol Venereol; 1998 Feb; 125(2):94-7. PubMed ID: 9747221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pilot study evaluating anxiety and depressive scores in acne patients treated with isotretinoin.
    Ferahbas A; Turan MT; Esel E; Utas S; Kutlugun C; Kilic CG
    J Dermatolog Treat; 2004 Jun; 15(3):153-7. PubMed ID: 15204147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A population-based analysis of laboratory abnormalities during isotretinoin therapy for acne vulgaris.
    Zane LT; Leyden WA; Marqueling AL; Manos MM
    Arch Dermatol; 2006 Aug; 142(8):1016-22. PubMed ID: 16924051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in laboratory variables induced by isotretinoin treatment of acne.
    Michaëlsson G; Vahlquist A; Mobacken H; Hersle K; Landegren J; Rönnerfält L; Nordin K; Franzén K; Pettersson U
    Acta Derm Venereol; 1986; 66(2):144-8. PubMed ID: 2424238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of clinical efficacy, side effects, and laboratory changes among patients with acne vulgaris receiving single versus twice daily dose of oral isotretinoin.
    Ahmad HM
    Dermatol Ther; 2015; 28(3):151-7. PubMed ID: 25754162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma homocysteine level is elevated in patients on isotretinoin therapy for cystic acne: a prospective controlled study.
    Polat M; Lenk N; Bingöl S; Oztaş P; Ilhan MN; Artüz F; Alli N
    J Dermatolog Treat; 2008; 19(4):229-32. PubMed ID: 18608712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medium dose isotretinoin for the treatment of acne.
    Hermes B; Praetel C; Henz BM
    J Eur Acad Dermatol Venereol; 1998 Sep; 11(2):117-21. PubMed ID: 9784036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An observational study of isotretinoin recipients treated for acne in a health maintenance organization.
    McElwee NE; Schumacher MC; Johnson SC; Weir TW; Greene SL; Scotvold MJ; Hunter JR; Dinan BJ; Jick H
    Arch Dermatol; 1991 Mar; 127(3):341-6. PubMed ID: 1825596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of depression, anxiety and life quality in acne vulgaris patients who were treated with either isotretinoin or topical agents.
    Kaymak Y; Taner E; Taner Y
    Int J Dermatol; 2009 Jan; 48(1):41-6. PubMed ID: 19126049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of isotretinoin therapy on lipoprotein (a) serum levels.
    Georgala S; Schulpis KH; Potouridou I; Papadogeorgaki H
    Int J Dermatol; 1997 Nov; 36(11):863-4. PubMed ID: 9427083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Side effects of treatment with isotretinoin in patients with acne].
    Bergler-Czop B; Brzezińska-Wcisło L
    Pol Merkur Lekarski; 2005 Jun; 18(108):680-5. PubMed ID: 16124383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of combined azelaic acid cream plus oral minocycline with oral isotretinoin in severe acne.
    Gollnick HP; Graupe K; Zaumseil RP
    Eur J Dermatol; 2001; 11(6):538-44. PubMed ID: 11701404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe acute myopathy induced by isotretinoin.
    Fiallo P; Tagliapietra AG
    Arch Dermatol; 1996 Dec; 132(12):1521-2. PubMed ID: 8961893
    [No Abstract]   [Full Text] [Related]  

  • 17. Primary carnitine deficiency: adult onset lipid storage myopathy with a mild clinical course.
    Vielhaber S; Feistner H; Weis J; Kreuder J; Sailer M; Schröder JM; Kunz WS
    J Clin Neurosci; 2004 Nov; 11(8):919-24. PubMed ID: 15519880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isotretinoin does not induce insulin resistance in patients with acne.
    Ertugrul DT; Karadag AS; Tutal E; Akin KO
    Clin Exp Dermatol; 2011 Mar; 36(2):124-8. PubMed ID: 20804507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-dose isotretinoin in the treatment of acne vulgaris.
    Amichai B; Shemer A; Grunwald MH
    J Am Acad Dermatol; 2006 Apr; 54(4):644-6. PubMed ID: 16546586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-pulsed dye laser-mediated photodynamic therapy combined with topical therapy for mild to severe comedonal, inflammatory, or cystic acne.
    Alexiades-Armenakas M
    J Drugs Dermatol; 2006 Jan; 5(1):45-55. PubMed ID: 16468292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.